Craig Adam R 4
4 · X4 Pharmaceuticals, Inc · Filed Oct 31, 2025
Insider Transaction Report
Form 4
Craig Adam R
DirectorExecutive Chairman
Transactions
- Award
Stock Option (right to buy)
2025-10-29+2,329,154→ 2,329,154 totalExercise: $1.42Exp: 2035-08-12→ Common Stock (2,329,154 underlying)
Footnotes (1)
- [F1]Represents stock options granted to the Reporting Person on August 12, 2025, which were subject to a performance-based vesting condition that was satisfied on October 29, 2025. One third of the shares subject to the option shall vest on August 12, 2026, with the remainder vesting in equal installments each successive month thereafter for a period of 24 months, subject to the Reporting Person continuing to provide services through each such date.